BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1119 related articles for article (PubMed ID: 16938518)

  • 1. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
    Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Scarpelli M; Lòpez Beltran A
    Hum Pathol; 2006 Sep; 37(9):1137-44. PubMed ID: 16938518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of endothelin-1 and endothelin-A and endothelin-B receptors in high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Lòpez Beltran A; Cheng L; Montorsi F; Scarpelli M
    Eur Urol; 2007 Dec; 52(6):1682-9. PubMed ID: 17368711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of ELAV-like protein HuR is associated with increased COX-2 expression in atrophy, high-grade prostatic intraepithelial neoplasia, and incidental prostate cancer in cystoprostatectomies.
    Barbisan F; Mazzucchelli R; Santinelli A; Lopez-Beltran A; Cheng L; Scarpelli M; Montorsi F; Montironi R
    Eur Urol; 2009 Jul; 56(1):105-12. PubMed ID: 18468781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimens.
    Montironi R; Mazzucchelli R; Santinelli A; Scarpelli M; Beltran AL; Bostwick DG
    Hum Pathol; 2005 Jun; 36(6):646-54. PubMed ID: 16021571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER-2 expression and gene amplification in high-grade PIN and prostate cancer.
    Montironi R; Mazzucchelli R
    Arch Ital Urol Androl; 2006 Dec; 78(4):135-9. PubMed ID: 17269616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of prostate tumor overexpressed 1 in cystoprostatectomies with incidental and insignificant prostate cancer. Further evidence for field effect in prostatic carcinogenesis.
    Mazzucchelli R; Barbisan F; Santinelli A; Lopez-Beltran A; Cheng L; Scarpelli M; Montironi R
    Hum Pathol; 2011 Dec; 42(12):1931-6. PubMed ID: 21676431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
    J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-level TOP2A amplification in prostate cancer is associated with HER2 duplication, androgen resistance, and decreased survival.
    Murphy AJ; Hughes CA; Barrett C; Magee H; Loftus B; O'Leary JJ; Sheils O
    Cancer Res; 2007 Mar; 67(6):2893-8. PubMed ID: 17363613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-Methylacyl coenzyme A racemase, Ki-67, and topoisomerase IIalpha in cystoprostatectomies with incidental prostate cancer.
    Santinelli A; Mazzucchelli R; Barbisan F; Lopez-Beltran A; Cheng L; Scarpelli M; Montironi R
    Am J Clin Pathol; 2007 Oct; 128(4):657-66. PubMed ID: 17875519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer.
    Morichetti D; Mazzucchelli R; Stramazzotti D; Santinelli A; Lopez-Beltran A; Scarpelli M; Bono AV; Cheng L; Montironi R
    BJU Int; 2010 Oct; 106(7):1072-80. PubMed ID: 20201837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of ezrin in prostatic intraepithelial neoplasia.
    Pang ST; Fang X; Valdman A; Norstedt G; Pousette A; Egevad L; Ekman P
    Urology; 2004 Mar; 63(3):609-12. PubMed ID: 15028477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER2 protein expression and gene amplification in androgen-independent prostate cancer.
    Reese DM; Small EJ; Magrane G; Waldman FM; Chew K; Sudilovsky D
    Am J Clin Pathol; 2001 Aug; 116(2):234-9. PubMed ID: 11488070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of prostate stem cell antigen in cystoprostatectomies with incidental prostate cancer.
    Mazzucchelli R; Barbisan F; Santinelli A; Lopez-Beltran A; Cheng L; Scarpelli M; Montironi R
    Int J Immunopathol Pharmacol; 2009; 22(3):755-62. PubMed ID: 19822092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is incidentally detected prostate cancer in patients undergoing radical cystoprostatectomy clinically significant?
    Mazzucchelli R; Barbisan F; Scarpelli M; Lopez-Beltran A; van der Kwast TH; Cheng L; Montironi R
    Am J Clin Pathol; 2009 Feb; 131(2):279-83. PubMed ID: 19141388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
    Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
    Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of high-grade prostatic intraepithelial neoplasia in prostate gland of Korean men: comparisons between radical prostatectomy and cystoprostatectomy.
    Han KS; Jeong IG; Joung JY; Yang SO; Chung J; Seo HK; Park WS; Lee KH
    Urology; 2007 Dec; 70(6):1100-3. PubMed ID: 18158026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer.
    Minner S; Jessen B; Stiedenroth L; Burandt E; Köllermann J; Mirlacher M; Erbersdobler A; Eichelberg C; Fisch M; Brümmendorf TH; Bokemeyer C; Simon R; Steuber T; Graefen M; Huland H; Sauter G; Schlomm T
    Clin Cancer Res; 2010 Mar; 16(5):1553-60. PubMed ID: 20179235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of low level HER-2/neu gene amplification in prostate cancer by fluorescence in situ hybridization.
    Liu HL; Gandour-Edwards R; Lara PN; de Vere White R; LaSalle JM
    Cancer J; 2001; 7(5):395-403. PubMed ID: 11693898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
    Zhigang Z; Wenlv S
    Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.